(6-Chloro-1H-benzo[d]imidazol-2-yl)(4-methylpiperazin-1-yl)methanone maleate

Catalog No. :
ACNQUZ844
CAS No. :
869497-75-6
Molecular Formula :
C17H19ClN4O5
Molecular Weight :
394.82

IUPAC Name:JNJ10191584 maleate

(6-Chloro-1H-benzo[d]imidazol-2-yl)(4-methylpiperazin-1-yl)methanone maleate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$186.00Login to see priceInquiryInquiry
10mg98%$285.00Login to see priceInquiryInquiry
25mg98%$569.00Login to see priceInquiryInquiry
50mg98%$895.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(6-Chloro-1H-benzo[d]imidazol-2-yl)(4-methylpiperazin-1-yl)methanone maleate
IUPAC NameJNJ10191584 maleate
MDL No.MFCD08703121
Molecular FormulaC17H19ClN4O5
Molecular Weight394.82
SMILESOC(/C=C\C(O)=O)=O.O=C(N1CCN(CC1)C)C(NC2=C3)=NC2=CC=C3Cl
InChI KeyKOTJFAYEELTYCZ-BTJKTKAUSA-N
SynonymC13H15ClN4O.C4H4O4 | HMS3413M16 | CS-0028873 | HB1596 | JNJ10191584 (maleate) | SCHEMBL602941 | JNJ 10191584 maleate salt | HMS3677M16 | (6-Chloro-1H-benzimidazol-2-yl)-(4-methylpiperazin-1-yl)methanone Maleate | JNJ 10191584 maleate salt, >=98% (HPLC) |
CAS No.869497-75-6
PubChem CID11718163

Synthetic Route by SureRoute

1. ACNQUZ844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACXMET238 route compound structure diagram
    ACXMET23839811-14-8 In Stock
  4. Then
  5. ACNQUZ844 route product structure diagram
    ACNQUZ844869497-75-6
Inquiry

2. ACNQUZ844 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  4. Then
  5. ACNQUZ844 route product structure diagram
    ACNQUZ844869497-75-6
Inquiry

Comments (0)